晶珠品牌怎么样 申请店铺

我要投票 晶珠在冬虫夏草行业中的票数:9 更新时间:2024-11-23
晶珠是哪个国家的品牌?「晶珠」是 青海晶珠藏药高新技术产业股份有限公司 旗下著名品牌。该品牌发源于山东,由创始人赵丽娟在1998-05-08期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
晶珠怎么样

青海晶珠藏药高新技术产业股份有限公司是由吉林博士乐制药公司于1998年兼并西宁市医药总公司所属的青海昆仑制药厂组建而成的,随着企业的不断发展壮大,于2004年初以青海晶珠藏药高新技术产业股份有限公司为母公司组建成立青海晶珠藏药高新技术产业集团。2005年,“晶珠”商标被国家工商总局评定为“中国驰名商标”。

现集团下辖18个子公司,集药品生产、药品经营批发、医疗保健、科研教育、旅游文化等产业于一体。拥有14个国家独家专利藏药、100多种新型药品、具有青藏特色和东北长白山特色的保健品200多种。在治疗和预防心脑血管病、肝病、妇科病、胃病、风湿骨病、前列腺疾病、皮肤病、眼病、感冒、失眠类疾病等方面疗效显著。

经专业权威机构评估集团总资产58.98亿,其中品牌价值39.11亿,商标权属8.3亿,产品专利7.3亿,固定资产及流动资金4.27亿。十余年来,集团聚积了一大批科研、管理、生产、企划、营销、财会等方面的高级人才,公司管理层平均年龄31岁,硕士学历以上人才占5%,本科学历人才占65%,专科学历人才占30%,形成知识化、年轻化、技能化朝气蓬勃的晶珠团队。

晶珠藏药集团致力于打造现代藏药精品,建设了先进的CO2超临界萃取、水提、醇提、真空喷雾干燥技术、微波灭菌、超声波诱导萃取、大孔树脂吸附等设备及技术,并建成滴丸剂、微囊剂、微粉剂、栓剂、片剂、胶囊剂、颗粒剂、水剂、酒剂、丸剂、散剂等11种现代剂型的工艺设备。并根据药物自身的特性,结合传统中藏药经典组方,采用先进的高效液相、高效气相、薄层扫描、指纹图谱检测技术,对药物的有效成分进行精确的分析和提取,使药物具有“速效、高效、长效”“毒性小、副作用小、剂量小”“使用方便、携带方便、储藏方便、生产方便、运输方便”等特色,将藏药从传统手工作坊式的落后生产提升到现代化高科技大工业生产。实现了“量小、效宏、安全、可靠”的现代制药标准。

晶珠藏药集团在科研上狠下功夫,先后成立了青海昆仑药物研究所、青海省省级科研技术中心、北京崇文区中藏医药研究院、吉林省中藏医药研究院、青海晶珠中藏医院研究院5个科研机构,由中国科学院藏药现代化研究中心主任、中国科学院原西北高原生物研究所所长张宝琛教授担任晶珠藏药集团首席科学顾问兼集团科技部部长,领军集团的科研队伍进行新特药品的开发,并以“辨证施治”为指导思想,筛选疗效确切的药品或组方,再以中藏医院、社区诊所、中国家庭健康普及项目健康推广中心、中国民族药学会科技发展中心等为临床科研阵地,“以医带药”形成独具特色的中藏医诊疗方法——“晶珠疗法”。通过电话呼叫中心、网络信息化建设、ERP管理软件的开发和利用,积极为患者提供疗效确切的治疗办法和药品。

在品牌建设和保护上,企业所研发的大部分药品都申请了国家专利,保护了企业的知识产权,杜绝了重复建设,也为企业的发展预留了空间。1999年至今,晶珠藏药召开多次“晶珠藏药社会评鉴会”,由服用过晶珠产品的患者直接讲述用药疗效及感受,对企业和产品作评鉴,大大提高了产品与企业的口碑与社会影响力。并先后在全国投入10多亿的广告宣传,在全国200多个大中城市的主流媒体进行强势广告宣传,使“晶珠”品牌深入人心,被国家工商总局评定为“中国驰名商标”!

在市场磨练和企业内训的双重作用下,晶珠集团打造出了一支高效的管理团队和市场营销队伍。在全国各大城市设立了上百个办事处,销售网络已覆盖县级市场。药品进入全国许多家医院、上万家药店,疗效受到医生和患者的广泛好评。同时设立“晶珠中藏医药培训中心”,常年培训中藏医药专业的咨询服务人员。近几年在国家严格管理整顿医药市场、原材料和人力成本上涨、推广成本不断上涨的情况下,晶珠的销售额以年平均30%的速度向上增长。

青海省藏药生产企业众多,但市场网络不健全。2005年年底,在青海省政府的提议下,由晶珠藏药集团牵头对青海省的中藏药企业进行营销整合,建立团购团售厂商联盟。团购团售厂商联盟本着“五选五不选”的原则选择疗效好的、不选疗效差的、选择有品牌的、不选市场反馈差的、选择有信誉的、不选没信誉的、选择价格适中的、不选价格过高的药品。以联盟的名义统一和各大商业和药店洽谈,既可高扣率上柜,节约终端上柜的费用,又可快速结款。在药店建立“全国民族药连锁展示专柜”,将民族药集中陈列展示,统一配有受过民族药知识专业训练的咨询讲解员,通过细致的服务发挥藏药在治疗疑难杂症方面的优势,使老百姓有了确切的用药指导,辨症施治提高患者对中藏药的认可度。团售团购厂商联盟以“六统一”实现“三节约”达到“三盈利”的目的:“六统一”即统一采购、统一进终端、统一培训、统一宣传、统一销售、统一服务;“三节约”即节约人力、节约财力、节约物力;“三方便”即厂家销售方便、商家采购方便、患者购药方便;“三盈利”即厂家盈利、商家盈利、联盟盈利。

晶珠藏药与卫生部、全国妇联、中国女性健康系列活动组委会联合成立“中国家庭健康普及项目健康服务推广中心”。以女性和老年人群为主体,将健康教育、医学常识、就医用药指导广泛地深入到城市社区,提高家庭健康意识和自我保健能力。同时向全国十九个省市的二十个城市发行“家庭常备药箱”、“家庭健康卡”,建立了300座席的家庭健康呼叫中心,使老百姓享受贴心的健康指导、优惠的就医用药、免费健康体检等服务。将健康带进每一个社区、每一个家庭。

2008年,晶珠藏药集团整合集团整体优势,集中致力于中藏医药产业化、规模化、集约化纵深发展,建立集药材种植、药品生产、药品仓储、药品批发销售、售后服务一条龙的完善医药健康产业链。在销售上,大胆进行多种销售渠道与网络的开发和尝试,在北京建立崇文区藏文化馆,成为藏文化藏医药的宣传阵地,并建立北京崇文晶珠藏药中医门诊部,医药结合医药并重。同时建立晶珠得玉养生餐厅,将藏族歌舞、藏食药膳与中国几千年的饮食养生文化相结合,取得了良好的经济效益。在仓储物流上,晶珠藏药生物园区的大楼主体已竣工,总建筑面积19050m2,这里将被打造成为“西部药都”,成为西部的药物配送中心和仓储中心,从而解决西部药品的仓储与物流配送问题。在售后服务方面,建立晶珠健捷会员俱乐部,打造中国最大的健康管理顾问平台,为会员提供健康知识普及、健康管理与干预、疾病治疗、导医导药等服务……,实行立体创新会员制营销,使会员享受到最低折扣的产品、便捷实惠的服务。

近年,晶珠藏药集团承担了青海省大通县“鹞子沟、老爷山生态旅游资源开发”项目的设计和规划。目的在于利用原始的生态环境种植藏药的稀缺品种及带动青海的旅游产业发展。天然藏药更新与人工培育相结合,使藏药资源的开发利用与生态保护步入良性发展轨道,达到经济、社会、生态的谐调发展。晶珠藏药集团在青海省西宁市湟中县和乐都县麦雪乡建立的3500亩退垦还林种植基地,已按国家GAP标准种植了几十种高附加值、高技术含量的原生态藏药材,并将其形成药材种植研究基地,打造中藏药材、珍稀物种的引种驯化、种植、养殖基地及退垦还林、西繁东育的农业现代化基地,采用“公司+基地+农户”的形式,收购当地农户种植的中藏药材,增加农牧民收入,带领当地农牧民脱贫致富,使生态建设与经济发展达到完美的和谐统一。

10余年来,晶珠藏药在推进藏药现化化生产、中藏新特药研发、品牌建设与保护、终端网络建设与维护、团购团售厂商联盟、医药健康产业化集约化纵深发展上付出了艰苦的努力,也取得了一定的成就!

晶珠藏药在全国制药界的排名已经进入前30位;

晶珠藏药集团已成为全国现代成品藏药最大的市场占有者之一;

晶珠藏药集团研发生产的14种独家专利产品已稳居国内同行业的首位;

晶珠商标已成为青海藏药界唯一的“中国驰名商标”。

2002年5月25日,胡锦涛主席来到晶珠藏药集团青海GMP生产基地视察,并对晶珠藏药集团给予了高度评价:“你们在现代藏药的研发和生产上取得了非常好的成绩,希望你们更好的发展企业带动西部经济发展,带动农牧民致富,更好的发展民族医药事业”。

这是一支传承与创新并进的团队;这是一支传统与现代融合的团队;这是一支具有高度战斗力的铁军。这支团队,这支铁军就是晶珠人!现在晶珠人正以自己的方式影响着这个世界。而影响源于实力,影响源于眼光,影响源于气魄。晶珠藏药以其强大的资金实力、品牌实力、研发实力、营销实力,振兴中国民族医药,打破西药一统天下的世界医药格局,打造藏药、中药、西药三分天下新局面,成为世界级民族医药企业。
古有晶珠本草今有晶珠藏药

晶珠以藏药立身,藏药因晶珠而更扬名;晶珠得名于藏医药巨献《晶珠本草》,晶珠将传统藏药发扬光大并现代化规模生产;有传统藏药才有晶珠,有晶珠才有现代藏药,晶珠被业内称之为现代藏药的典范;晶珠藏药的处方来源于《晶珠本草》等藏药经典著作,《晶珠本草》因晶珠藏药而更加引人注目;因此,藏医藏药是晶珠的资源库、生命源,晶珠是藏药的品牌平台、传播中心、团售总部!

业内人称藏药乃数晶珠,晶珠像征藏药。由于晶珠在现代藏药的发展上取得的非常骄人的业绩,由于晶珠集团本身强大的资本实力、营销网络实力、科研开发实力、新品研发实力及国家一直以来的支持,使晶珠成为现代藏药代名词,成为现代藏药的象征;藏药是晶珠的魂,晶珠是藏药的形。

藏药因晶珠而更加发展,晶珠因藏药而壮大!晶珠藏药,因发展而强盛,因成功而壮大!晶珠闻名海内外,藏药造福亿万人!

Qinghai Jingzhu Tibetan medicine high tech Industry Co., Ltd. was established by Jilin doctoral Pharmaceutical Co., Ltd. in 1998 by annexing Qinghai Kunlun pharmaceutical factory affiliated to Xining Pharmaceutical Corporation. With the continuous development of the enterprise, Qinghai Jingzhu Tibetan medicine high tech Industry Co., Ltd. was established as the parent company of Qinghai Jingzhu Tibetan medicine high tech Industry Co., Ltd. in early 2004 。 In 2005, "Jingzhu" trademark was appraised as "China famous trademark" by the State Administration for Industry and commerce. Now the group has 18 subsidiaries, integrating pharmaceutical production, pharmaceutical wholesale, medical care, scientific research and education, tourism and culture industries. It has 14 national exclusive patent medicines, more than 100 new medicines, more than 200 health products with the characteristics of Qinghai Tibet and Changbai Mountain in Northeast China. In the treatment and prevention of cardiovascular and cerebrovascular disease, liver disease, gynecological disease, stomach disease, rheumatic bone disease, prostate disease, skin disease, eye disease, cold, insomnia and other diseases, the effect is significant. The group's total assets are 5.898 billion, including 3.911 billion brand value, 830 million trademark ownership, 730 million product patents and 427 million fixed assets and working capital. Over the past ten years, the group has accumulated a large number of senior talents in scientific research, management, production, planning, marketing, accounting and other aspects. The average age of the company's management is 31 years old, 5% of them have master's degree or above, 65% of them have bachelor's degree, 30% of them have junior college degree, forming a vibrant crystal team with knowledge, youth and skills. Jing Zhu Tibetan medicine group is committed to building modern Tibetan medicine products. Advanced CO2 supercritical extraction, water extraction, alcohol extraction, vacuum spray drying technology, microwave sterilization, ultrasonic induced extraction, macroporous resin adsorption and other equipment and technology have been built, and 11 kinds of dripping pills, microcapsules, micropowder agents, suppository, tablets, capsules, granules, water agents, wine, pills, and powder have been established. Process equipment of substitute dosage form. According to the characteristics of the drug itself, combined with the traditional Chinese Tibetan medicine classic formula, the advanced high-performance liquid phase, high-efficiency gas phase, thin-layer scanning and fingerprint detection technology are used to accurately analyze and extract the effective ingredients of the drug, so that the drug has "quick effect, high efficiency, long-term effect", "small toxicity, small side effect, small dosage", "easy to use, easy to carry, convenient to store With the characteristics of convenient production and transportation, Tibetan medicine has been promoted from the backward production of traditional manual workshop to the modern high-tech industrial production. The modern pharmaceutical standard of "small quantity, great effect, safety and reliability" has been realized. Jingzhu Tibetan medicine group has made great efforts in scientific research. It has successively established five scientific research institutions, namely, Qinghai Kunlun Pharmaceutical Research Institute, Qinghai provincial scientific research and technology center, Beijing Chongwen District China Tibet Pharmaceutical Research Institute, Jilin Province China Tibet Pharmaceutical Research Institute and Qinghai Jingzhu China Tibet Hospital Research Institute, which are headed by the research center of Tibetan medicine modernization of Chinese Academy of Sciences and the former Northwest Plateau Biological Research Institute of Chinese Academy of Sciences Professor Zhang Baochen, director of the Institute, serves as the chief scientific consultant and head of the group's science and Technology Department of Jingzhu Tibetan medicine group, leading the scientific research team of the group in the development of new and special drugs, and taking "syndrome differentiation and treatment" as the guiding ideology, screening the drugs or groups with definite curative effect, and then taking the development of science and technology of China Tibet hospital, community clinic, health promotion center of China family health popularization project and China National pharmacy Association The center is the position of clinical scientific research and forms the unique diagnosis and treatment method of Chinese and Tibetan Medicine - "crystal bead therapy". Through the telephone call center, network information construction, ERP management software development and utilization, actively provide patients with effective treatment methods and drugs. In terms of brand building and protection, most of the drugs researched and developed by the enterprise have applied for national patents, protecting the intellectual property rights of the enterprise, eliminating repeated construction and reserving space for the development of the enterprise. Since 1999, Jingzhu Tibetan medicine has held many "Jingzhu Tibetan medicine social evaluation meetings", in which patients who have taken Jingzhu products directly talk about the efficacy and feelings of medication, and evaluate enterprises and products, greatly improving the reputation and social influence of products and enterprises. And has invested more than 1 billion advertising in the country, and carried out strong advertising in the mainstream media of more than 200 large and medium-sized cities across the country, so that the "Jingzhu" brand is deeply rooted in the people's hearts, and is rated as "China's famous trademark" by the State Administration of industry and Commerce! Under the dual functions of market training and enterprise internal training, Jingzhu group has created an efficient management team and marketing team. Hundreds of offices have been set up in major cities across the country, and the sales network has covered the county-level market. Drugs have entered many hospitals and tens of thousands of pharmacies in China, and their efficacy has been widely praised by doctors and patients. At the same time, the "Jingzhu Sino Tibetan medicine training center" is set up to train the professional consulting service personnel of Sino Tibetan medicine all the year round. In recent years, with the strict management and rectification of the pharmaceutical market, the rising cost of raw materials and human resources, and the rising cost of promotion, the sales volume of Jingzhu has increased at an average annual rate of 30%. There are many Tibetan medicine enterprises in Qinghai Province, but the market network is not perfect. At the end of 2005, under the proposal of Qinghai provincial government, Jingzhu Tibetan medicine group led the marketing integration of Chinese and Tibetan medicine enterprises in Qinghai Province, and established a group purchase and group sale manufacturer alliance. In line with the principle of "five choices, five no choices", the alliance of group buying and selling manufacturers chooses the drugs with good curative effect, bad curative effect, brand, poor market feedback, credibility, reputation, moderate price and high price. In the name of the alliance, we can negotiate with all major businesses and pharmacies, which can not only reduce the cost of terminal listing, but also settle the payment quickly. In the drugstore, a "national ethnic medicine chain display counter" is established to display ethnic medicine in a centralized way, which is equipped with a consultant and commentator who has received professional training in ethnic medicine knowledge. Through careful service, the advantages of Tibetan medicine in the treatment of difficult and miscellaneous diseases are brought into play, so that the common people have accurate drug guidance, and disease differentiation and treatment can improve the patients' recognition of Chinese and Tibetan medicine. The alliance of group sale and group purchase manufacturers achieves the goal of "three savings" and "Three Profits" by "six unification": unified purchase, unified terminal entry, unified training, unified publicity, unified sales and unified service; "three savings" means saving human, financial and material resources; "three conveniences" means convenient sales of manufacturers, convenient purchase of merchants and convenient purchase of drugs for patients "Three Profits" refers to the profits of manufacturers, businesses and alliances. Jingzhu Tibetan medicine and Ministry of health, all China Women's Federation and organizing committee of China Women's health series jointly established "China family health popularization project health service promotion center". With women and the elderly as the main body, health education, medical common sense and medical guidance are widely extended to urban communities to improve family health awareness and self-care ability. At the same time, it issued "family regular medicine box" and "family health card" to 20 cities in 19 provinces and cities nationwide, established 300 seat family health call center, so that people can enjoy intimate health guidance, preferential medical treatment, free health examination and other services. Bring health into every community, every family. In 2008, Jingzhu Tibetan medicine group integrated the overall advantages of the group, concentrated on the in-depth development of the industrialization, scale and intensification of Chinese and Tibetan medicine, and established a complete pharmaceutical and health industry chain integrating the cultivation of medicinal materials, pharmaceutical production, pharmaceutical storage, wholesale sales and after-sales service. In terms of sales, we should boldly develop and try various sales channels and networks, establish a Tibetan Culture Museum in Chongwen District in Beijing, become the propaganda position of Tibetan culture and medicine, and establish a Tibetan medicine outpatient department in Chongwen Jingzhu District in Beijing, paying equal attention to the combination of medicine and medicine. At the same time, Jingzhu Deyu health preservation restaurant is established, which combines Tibetan songs and dances, Tibetan medicine and diet with thousands of years of Chinese food and health preservation culture, and achieves good economic benefits. In terms of storage and logistics, the main building of Jingzhu Tibetan medicine biological park has been completed, with a total building area of 19050m2. It will be built into the "western medicine capital" and become the drug distribution center and storage center in the west, so as to solve the problem of drug storage and logistics distribution in the West. In terms of after-sales service, we will establish Jingzhu Jianjie member club, build the largest health management consulting platform in China, and provide members with services such as health knowledge popularization, health management and intervention, disease treatment, medical guidance and medicine guidance To implement the three-dimensional innovative membership marketing, so that members can enjoy the lowest discount products, convenient and affordable services. In recent years, Jingzhu Tibetan medicine group has undertaken the design and planning of "yaozigou and LAOYESHAN ecotourism resources development" project in Datong County, Qinghai Province. The purpose is to use the original ecological environment to plant rare Tibetan medicine varieties and promote the development of tourism industry in Qinghai. The combination of natural Tibetan medicine renewal and artificial cultivation makes the development and utilization of Tibetan medicine resources and ecological protection step into a benign development track, achieving the harmonious development of economy, society and ecology. Jingzhu Tibetan medicine group has established a 3500 Mu cultivation base for returning cultivated land to forest in Maixue Township, Huangzhong County and Ledu County, Xining City, Qinghai Province. It has planted dozens of original ecological medicinal materials with high added value and high technology content according to the national gap standard, and formed a research base for planting medicinal materials. It has also built a base for introducing and domesticating, planting and breeding of Chinese medicinal materials and rare species as well as for returning cultivated land to forest and breeding in the West and East In the form of "company + base + farmer", the agricultural modernization base of Beijing will purchase the Chinese and Tibetan medicinal materials planted by local farmers, increase the income of farmers and herdsmen, lead local farmers and herdsmen to get rid of poverty and become rich, and make the ecological construction and economic development reach a perfect harmonious unity. Over the past 10 years, Jingzhu Tibetan medicine has made great efforts in promoting the materialized production of Tibetan medicine, the research and development of new Chinese and Tibetan special medicine, brand construction and protection, terminal network construction and maintenance, group purchase and group sale manufacturer alliance, and intensive development of medical health industrialization, and has also made some achievements! Jingzhu Tibetan medicine ranks in the top 30 in the national pharmaceutical industry; Jingzhu Tibetan medicine group has become one of the largest market holders of modern finished Tibetan medicine in China; 14 kinds of exclusive patent products researched and produced by Jingzhu Tibetan medicine group have ranked first in the same industry in China; Jingzhu trademark has become the only "China famous trademark" in Qinghai Tibetan medicine industry. On May 25, 2002, President Hu Jintao visited the Qinghai GMP production base of Jingzhu Tibetan medicine group, and spoke highly of Jingzhu Tibetan medicine group: "you have made very good achievements in the research and development and production of modern Tibetan medicine. I hope you can better develop enterprises to drive the economic development of the West, drive farmers and herdsmen to become rich, and better develop national medicine.". This is a team of inheritance and innovation; this is a team of traditional and modern integration; this is an iron army with high combat effectiveness. This team, this iron army is Jingzhu people! Now Jingzhu people are influencing the world in their own way. The influence comes from strength, vision and spirit. Jingzhu Tibetan medicine, with its strong capital strength, brand strength, R & D strength and marketing strength, revitalizes Chinese national medicine, breaks the world pharmaceutical pattern of Western medicine dominating the world, creates a new situation of three parts of Tibetan medicine, traditional Chinese medicine and Western medicine, and becomes a world-class national pharmaceutical enterprise. In ancient times, there were beads of herbal medicine. Now, there are beads of Tibetan medicine. The beads of Tibetan medicine stand for Tibetan medicine. Tibetan medicine is more famous because of the beads. The beads got their name from the Tibetan medicine masterpiece "the beads of herbal medicine". The beads carry forward the traditional Tibetan medicine and present it

本文链接: https://brand.waitui.com/a836737df.html 联系电话:09716316716

千城特选小程序码

7×24h 快讯

主题指数ETF规模突破4000亿元 超八成产品年内浮盈

近年来,随着工具化产品持续丰富,主题指数ETF作为其中的一个分支,也实现了稳步增长。今年以来截至11月22日,主题指数ETF共“上新”42只新产品,目前共计423只,较年初规模增加174.77亿元,至4081.81亿元,增长4.47%。数据显示,今年以来截至11月22日,423只主题指数ETF(仅统计初始基金)中,有341只实现浮盈,占比达81%,其中有70只产品浮盈超30%。(财联社)

2分钟前

北京君正:公司异构多核处理器X2600、T41等已应用在扫地机器人等领域

北京君正在互动平台表示,公司推出的异构多核处理器X2600、T41等,已应用在扫地机器人、斗宠机器人等领域。(e公司)

2分钟前

上海电气与甘肃电投签订战略合作协议

上海电气消息,11月21日,在上海电气集团党委书记、董事长吴磊与甘肃省电力投资集团有限责任公司(简称“甘肃电投”)党委书记、董事长蒲培文的共同见证下,上海电气与甘肃电投共同签署战略合作框架协议。吴磊表示,当前,上海电气正积极响应国家“双碳”战略,加大在新能源技术研发、装备制造和项目建设等方面的投入,期待与甘肃电投在风光储氢、信息与数字化等领域进一步深化合作,共同推动中国能源产业从技术到应用的全产业链协同发展,为甘肃经济社会高质量发展作出更大贡献。(e公司)

2分钟前

美联储:杠杆对冲基金放大了8月份的市场抛售

美联储在其最新的金融稳定报告中表示,基础交易(对冲基金在国债市场上进行的杠杆套利)的指标仍接近历史最高水平。这导致对冲基金的杠杆率普遍偏高。但美联储表示,基础交易可能不是 8 月份市场大幅波动的主要原因。相反,美联储发现证据表明,一些对冲基金在日元中的杠杆头寸是一个重要因素——这与许多人的猜测相符,即日元套利交易是 8 月份交易量激增的一个主要原因。(新浪财经)

2分钟前

对冲基金持有的欧元空头头寸升至三年来最高水平

根据美国商品期货交易委员会(CFTC)的最新数据,杠杆基金在截至11月19日当周增加了欧元空头头寸,目前空头合约数量约61747份,为2021年10月以来的最高水平。基金还转而持有少量澳元净多头头寸。资产管理公司、对冲基金和其他投机交易员整体增加了美元多头头寸,当前美元多头合约金额达约233亿美元,创6月以来的最高水平。(新浪财经)

2分钟前

本页详细列出关于晶珠的品牌信息,含品牌所属公司介绍,晶珠所处行业的品牌地位及优势。
咨询